US pharmacists' effect as team members on patient care: Systematic review and meta-analyses

Medical Care

Volumn 48, Issue 10, 2010, Pages 923-933

  Chisholm Burns, Marie A ^a   Kim Lee, Jeannie ^a   Spivey, Christina A ^a   Slack, Marion ^a   Herrier, Richard N ^a   Hall Lipsy, Elizabeth ^a   Graff Zivin, Joshua ^b   Abraham, Ivo ^a   Palmer, John ^c   Martin, Jennifer R ^d   Kramer, Sandra S ^d   Wunz, Timothy ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d Arizona Health Sciences Library   (United States)

Author keywords

direct patient care; meta analysis; pharmacists; systematic review

Indexed keywords

HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; COCHRANE LIBRARY; DATA BASE; HEALTH CARE UTILIZATION; HEALTH SERVICE; HUMAN; MEDLINE; META ANALYSIS; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACIST; PRIORITY JOURNAL; PSYCINFO; QUALITY OF LIFE; SAFETY; SYSTEMATIC REVIEW; TEAMWORK; TREATMENT OUTCOME; UNITED STATES; ATTITUDE TO HEALTH; HUMAN RELATION; MEDICATION COMPLIANCE; ORGANIZATION AND MANAGEMENT; PHARMACY; PROFESSIONAL STANDARD; STATISTICS AND NUMERICAL DATA;

COMMUNITY PHARMACY SERVICES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MEDICATION ADHERENCE; PATIENT CARE TEAM; PATIENT EDUCATION AS TOPIC; PATIENT-CENTERED CARE; PHARMACISTS; PROFESSIONAL ROLE; PROFESSIONAL-PATIENT RELATIONS; UNITED STATES;

EID: 77957279314     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e3181e57962     Document Type: Article

References (50)

1. Yarnall KSH, Ostbye T, Krause KM, et al. Family physicians as team leaders: "time" to share the care. Prev Chronic Dis. 2009;6. Available at: http://www.cdc.gov/pcd/issues/2009/apr/08-0023.htm. Accessed June 10, 2009.
2. Kaboli PJ, Hoth AB, McClimon BJ. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166:955-964.
3. Kohn LT, Institute of Medicine. Academic Health Centers: Leading Change in the 21st Century. Washington, DC: National Academy Press; 2003.
4. Kohn LT, Corrigan JM, Donaldson MS. To Err Is Human. Washington, DC: National Academy Press; 2000.
5. Adams K, Corrigan JM, eds. Priority Areas for National Action. Transforming Health Care Quality. Washington, DC: The National Academies Press 2003.
6. Krantz JC Jr. The status of clinical service as a phase of pharmaceutical service. J Am Pharm Assoc. 1922;11:28-30.
7. Koshman SL, Charrois TL, Simpson SH, et al. Pharmacist care of patients with heart failure. a systematic review of randomized trials. Arch Intern Med. 2008;168:687-694.
8. Singhal PK, Raisch DW, Gupchup GV. The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research. Ann Pharmacother. 1999;33: 1336-1355.
9. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilization, costs, and patient outcomes. Cochrane Database Syst Rev. 2000:CD000336.
10. Pickard AS, Hung SY. An update on evidence of clinical pharmacy services' impact on health-related quality of life. Ann Pharmacother. 2006;40:1623-1634.
11. Ponniah A, Anderson B, Shakib S, et al. Pharmacists' role in the post-discharge management of patients with heart failure: a literature review. J Clin Pharm Ther. 2007;32:343-352.
12. Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med. 2003;25:144-153.
13. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28:421-436.
14. Machado M, Bajcar J, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007;41:1569-1582. (Pubitemid 47479786)
15. Machado M, Bajcar J, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007;41:1770-1781. (Pubitemid 350044338)
16. Machado M, Nassor N, Bajcar JM, et al. Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia. Ann Pharmacother. 2008;42:1195-1207.
17. Carter BL, Rogers M, Daly J, et al. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009; 169:1748-1755.
18. Kozma CM, Reeder CE, Shulz RM. Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther. 1993;15:1121-1132.
19. Higgin J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [Sept 2006]. Available at http://www.cochrane.dk/cochrane/ handbook/handbook.htm. Accessed January 2, 2008.
20. Egger M, Smith GD, Altman DG. Systematic Reviews in Health Care: Meta-analysis in Context. 2nd ed. London, United Kingdom: BMJ Books; 2001.
21. Agency for Healthcare Research and Quality (AHRQ). Making Health Care Safer: A Critical Analysis of Patient Safety Practices. Rockville, MD: US Department of Health and Human Services 2001
22. Roughead L, Semple S, Vitry A. The value of pharmacist professional services in the community setting. A systematic review of the literature 1990-2002. Available at: http://beta.guild.org.au/uploadedfiles/Re-search-and- Development-Grants-Program/Projects/2002-507-fr.pdf Accessed May 21, 2009.
23. Jadad AR, Moore A, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12.
24. Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull. 1999;47:15-17.
25. Anaya JP, Rivera JO, Lawson K, et al. Evaluation of pharmacist-managed diabetes mellitus under a collaborative drug therapy agreement. Am J Health Syst Pharm. 2008;65:1841-1845.
26. Bjornson DC, Hiner WO Jr, Potyk RP, et al. Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm. 1993;50:1875-1884.
27. Bond CA, Raehl CL. Clinical and economic outcomes of pharmacist-managed antimicrobial prophylaxis in surgical patients. Am J Health Syst Pharm. 2007;64:1935-1942.
28. Boyko WL Jr, Yurkowski PJ, Ivey MF, et al. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm. 1997;54:1591-1595.
29. Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc (2003). 2008;48:203-211; 3 p following 211.
30. Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003;29:691-698
31. Centers for Medicare and Medicaid Services, Office of the Actuary, National Health Statistics Group. Available at: http://www.cms.hhs.gov/ NationalHealthExpendData/downloads/tables.pdf. Accessed June 4, 2009.
32. Morrison A, Wertheimer AI. Evaluation of studies investigating the effectiveness of pharmacists' clinical services. Am J Health Syst Pharm. 2001;58:569-577.
33. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mel-litus. N Engl J Med. 1993;329:977-986
34. United Kingdom Prospective Diabetes Study Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
35. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296: 2563-2571.
36. Stamler J, Dyer AR, Shekelle RB, et al. Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow-up of Chicago cohorts. Cardiology. 1993;82:191-222.
37. Kannel WB, Neaton JD, Wentworth D, et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT: multiple risk factor intervention trial. Am Heart J. 1986;112:825-836.
38. Stamler J, Daviglus ML, Garside DB, et al. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all cause mortality and to longevity. JAMA. 2000;284:311-318.
39. Stamler J, Rose G, Stamler R, et al. INTERSALT study findings: public health and medical care implications. Hypertension. 1989;14:570-577.
40. MacMahon S, Cutler JA, Stamler J. Antihypertensive drug treatment: potential, expected, and observed effects on stroke and on coronary heart disease. Hypertension. 1989;13:I45-I50
41. Centers for Disease Control and Prevention (CDC), national center for health statistics. National health and nutrition examination survey 2005-2006. Hyattsville, MD: US department of health and human services, Centers for Disease Control and Prevention; 2007.
42. DeVol R, Bedroussian A. An Unhealthy America: The Economic Burden of Chronic Disease. Santa Monica, CA: Milken Institute; 2007.
43. Schober SE, Carroll MD, Lacher DA, et al. High serum total cholesterol\an indicator for monitoring cholesterol lowering efforts: US adults 2005-2006. Available at: http://www.cdc.gov/nchs/data/databriefs/db02.pdf. Accessed July 8, 2009.
44. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics\2007 update. A report from the American heart association statistics committee and stroke statistics subcommittee. Circulation. 2007;115:e69-e171.
45. National Diabetes Information Clearinghouse. National Diabetes Statistics, 2007. Available at: http://diabetes.niddk.nih.gov/DM/PUBS/ statistics/. Accessed July 8, 2009.
46. American Diabetes Association. Direct and indirect costs of diabetes in the United States. Available at: http://www.diabetes.org/diabetes-statistics/ cost-of-diabetes-in-us.jsp. Accessed July 8, 2009.
47. Slone Survey. Patterns of medication use in the United States 2005. Available at: http://web.bu.edu/slone/SloneSurvey/AnnualRpt/SloneSurvey WebReport2006.pdf. Accessed July 9, 2009.
48. Institute of Medicine. Preventing Medication Errors. Washington, DC: The National Academies Press 2007
49. Holland R, Desborough J, Goodyer L, et al. Does pharmacist-led medication review help to reduce hospital admissions and death in older people? A systematic review and meta-analysis. Br J Clin Pharmacol. 2008;65:303-316.
50. Coons SJ. Health outcomes and quality of life. In DiPiro JT, Talbert RL, Yee GC, et al, eds. Pharmacotherary: A Pathophysiologic Approach. 7th ed. New York: McGraw-Hill; 2008:O15-O23.